Revance Therapeutics, Inc. - COM (RVNC)

Q4 2018 13F Holders as of 12/31/2018

Type / Class
Equity / COM
Number of holders
98
Total Shares
31.8M
Shares change
+749K
Total reported value, excl. options
$640M
Value change
+$12.3M
Put/Call ratio
0.54
Number of buys
41
Number of sells
-48
Price
$20.13
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.